GlassScriptPhysician profile
Jacob M Moore
NPI 1851780928
$516.12
in general payments reported to CMS, 2019-2025
15 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.24 · 2022: $89.57 · 2023: $29.54 · 2024: $168 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $97.03 | 2024-2025 | Fanapt |
| Almatica Pharma LLC | $51.60 | 2022-2024 | Loreev Xr, Sertraline Hcl |
| Tempus Ai, INC | $50.67 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $49.47 | 2025 | Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $39.71 | 2021-2024 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.71 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $34.39 | 2021-2022 | |
| Immunitybio, INC. | $32.27 | 2025 | |
| Lundbeck LLC | $31.26 | 2024-2025 | Rexulti |
| Alkermes, INC. | $19.22 | 2021 | |
| Indivior INC. | $16.84 | 2023 | Perseris |
| E.R. Squibb & Sons, L.L.C. | $16.43 | 2024 | Cobenfy |
| Corium, LLC | $16.07 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.07 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.